Nîmes, France

Jean-Charles Bologna

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Charles Bologna. Retrieved from https://idiyas.com/inventor/jean-charles-bologna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean-Charles Bologna

Introduction

Jean-Charles Bologna is a notable inventor based in Nimes, France. He has made significant contributions to the field of biotechnology, particularly in the development of RNA compounds. His work has implications for various applications in medicine and genetic research.

Latest Patents

Jean-Charles Bologna holds a patent for an "Interfering RNA duplex having blunt-ends and 3'-modifications." This invention relates to double-stranded RNA compounds that feature at least one blunt end and include at least one 3'-end of a specific formula. This innovation is crucial for advancing RNA-based therapies and understanding gene regulation.

Career Highlights

Bologna is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research. His patent portfolio, though modest with a total of 1 patent, reflects his focused approach to innovation.

Collaborations

Throughout his career, Jean-Charles Bologna has worked alongside talented colleagues such as Jan Weiler and Jonathan Hall. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Jean-Charles Bologna exemplifies the spirit of innovation in biotechnology. His contributions, particularly in RNA research, highlight the importance of collaboration and focused research in advancing scientific knowledge.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…